Skip to content
WuXi AppTec Logo-White on Black

Advance your preclinical program with proven GLP pathways

Drive your development program forward with WuXi AppTec's GLP-compliant testing services. Our FDA, NMPA, and OECD inspected facilities deliver comprehensive safety assessments with the documentation precision required for global regulatory acceptance.

Contact our team to learn about our full range of services and capabilities for GLP-compliant preclinical testing.
0 K+
Safety Assessment Studies Conducted per Year
0 +
Environmentally Controlled Animal Rooms
0 M+
Square Feet of Lab Testing Space

Comprehensive General Toxicity
Testing from IND to NDA

WuXi AppTec delivers GLP studies of all sizes, durations, and complexities with unwavering regulatory compliance. We tailor toxicology studies to your specific requirements, supported by cutting-edge facilities, precision-controlled animal environments, tailored workspaces, and specialized scientific expertise.

IND-Enabling Toxicology Studies

For PCCs or INDs, we provide bioanalytical method development and validation services. If you have early-stage compounds, we recommend Early Diagnosis Tests (EDT), which detect and eliminate potentially toxic drug candidates, saving time and costs.

NDA-Enabling Toxicology Studies

For New Drug Application (NDA) submissions, we leverage the knowledge gained from working with your compound from the early stages of preclinical research to provide the best chance of success as you move through the clinical phases of development to market.

Your end-to-end preclinical GLP testing partner

With capabilities in safety assessment, DMPK/ADME, bioanalytical, pharmacology, Chemistry, Manufacturing and Controls (CMC) and analytical services all under one roof, WuXi AppTec is a global expert in GLP-compliant preclinical development testing and can support the full scope of your development program, from discovery to IND-enabling studies to NDA submission.